Literature DB >> 34186162

Structured edible lipid-based particle systems for oral drug-delivery.

Areen Ashkar1, Alejandro Sosnik2, Maya Davidovich-Pinhas3.   

Abstract

Oral administration is the most popular and patient-compliant route for drug delivery, though it raises great challenges due to the involvement of the gastro-intestine (GI) system and the drug bioavailability. Drug bioavailability is directly related to its ability to dissolve, transport and/or absorb through the physiological environment. A great number of drugs are characterized with low water solubility due to their hydrophobic nature, thus limiting their oral bioavailability and clinical use. Therefore, new strategies aiming to provide a protective shell through the GI system and improve drug solubility and permeability in the intestine were developed to overcome this limitation. Lipid-based systems have been proposed as good candidates for such a task owing to their hydrophobic nature which allows high drug loading, drug micellization ability during intestinal digestion due to the lipid content, and the vehicle physical protective environment. The use of edible lipids with high biocompatibility paves the bench-to-bedside translation. Four main types of structured lipid-based drug delivery systems differing in the physical state of the lipid phase have been described in the literature, namely emulsions, solid lipid nanoparticles, nanostructured lipid carriers, and oleogel-based particles. The current review provides a comprehensive overview of the different structured edible lipid-based oral delivery systems investigated up to date and emphasizes the contribution of each system component to the delivery performance, and the oral delivery path of lipids.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioavailability; Drug delivery; Emulsions; Nanostructured lipid carriers (NLCs); Oleogel-based particles; Oral administration; Solid lipid nanoparticles (SLNs); Water-solubility

Mesh:

Substances:

Year:  2021        PMID: 34186162     DOI: 10.1016/j.biotechadv.2021.107789

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  4 in total

1.  In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach.

Authors:  Yogeeta Agrawal; Kiran Patil; Hitendra Mahajan; Mrugendra Potdar; Pratiksha Joshi; Kartik Nakhate; Charu Sharma; Sameer N Goyal; Shreesh Ojha
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

2.  The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis.

Authors:  Amira Motawea; Walaa Ebrahim Abd El Hady; Ghada Ahmed El-Emam
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

3.  The Use of Sea Buckthorn Processing Products in the Creation of a Functional Biologically Active Food Emulsion.

Authors:  Lyubov V Tereshchuk; Ksenia V Starovoitova; Pavel A Vyushinsky; Konstantin A Zagorodnikov
Journal:  Foods       Date:  2022-07-26

Review 4.  Nanocarriers for delivery of siRNA as gene silencing mediator.

Authors:  Aideé Morales-Becerril; Liliana Aranda-Lara; Keila Isaac-Olivé; Blanca E Ocampo-García; Enrique Morales-Ávila
Journal:  EXCLI J       Date:  2022-08-01       Impact factor: 4.022

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.